These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31820218)

  • 21. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.
    Mueller SR; Koester S; Glanz JM; Gardner EM; Binswanger IA
    J Gen Intern Med; 2017 Mar; 32(3):277-283. PubMed ID: 27798775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
    Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
    Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.
    Chua KP; Brummett CM; Conti RM; Bohnert A
    JAMA Pediatr; 2020 Feb; 174(2):141-148. PubMed ID: 31841589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
    Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
    Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
    Ericson ØB; Eide D; Lobmaier P; Clausen T
    Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.
    Shoup JA; Mueller SR; Binswanger IA; Williams AV; Strang J; Glanz JM
    Pain Med; 2020 Oct; 21(10):2244-2252. PubMed ID: 32827044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
    Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
    J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EMS runs for suspected opioid overdose: implications for surveillance and prevention.
    Knowlton A; Weir BW; Hazzard F; Olsen Y; McWilliams J; Fields J; Gaasch W
    Prehosp Emerg Care; 2013; 17(3):317-29. PubMed ID: 23734988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
    Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
    Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities to boost naloxone awareness among people who misuse opioid analgesics who have not used illegal opioids.
    Gicquelais RE; Bohnert ASB; Fernandez AC
    Subst Abus; 2021; 42(3):372-376. PubMed ID: 32692621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Naloxone Co-Prescribing Rates for Older Adults Receiving Opioids via a Meds-to-Beds Program.
    Taliaferro L; McCarron M; Boylan PM; Bennett K; Shreffler M; Neely S; Walton B
    J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):16-25. PubMed ID: 36512672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [First Aid Training for Drug Overdose in Opioid Addicts and Provision of Take-Home Naloxone on Release from Prison: Feasibility Study from the Bavarian Model Project].
    Wodarz-von Essen HJ; Wolstein J; Pogarell O; Wodarz N
    Gesundheitswesen; 2023 Jun; 85(6):568-572. PubMed ID: 36126950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 38. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder.
    Bagley SM; Cabral H; Saia K; Brown A; Lloyd-Travaglini C; Walley AY; Rose-Jacobs R
    Addict Sci Clin Pract; 2018 Dec; 13(1):26. PubMed ID: 30547833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain.
    Behar E; Rowe C; Santos GM; Coffa D; Turner C; Santos NC; Coffin PO
    J Gen Intern Med; 2017 Mar; 32(3):291-295. PubMed ID: 27815762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.